Broliden K, Tolfvenstam T, Papadogiannakis N, Westgren M, Matt P, Lundqvist A, Skjöldebrand-Sparre L, Nyman M, Henter J I
Kliniskt virologiska laboratoriet, Karolinska institutet.
Lakartidningen. 1999 Nov 17;96(46):5066-9.
Parvovirus B19 is a common source of infection with a seroprevalence of 60-70 per cent in the adult population. The most common manifestation is erythema infectiosum ('fifth disease'), with exanthem, fever and upper airway symptoms in children. The infection can give rise to a multifacetted clinical picture and is probably underdiagnosed, particularly in risk groups (individuals with haemolytic anaemia or immunosuppression, and fetuses). Serological diagnosis can now be complemented with the demonstration of viral DNA using the PCR (polymerase chain reaction) test in various body fluids, or tissue biopsy. Recent years have witnessed manifest increase in clinical knowledge of parvovirus B19-associated complications, and their diagnosis and treatment.
细小病毒B19是一种常见的感染源,在成年人群中的血清阳性率为60%-70%。最常见的表现是传染性红斑(“第五病”),儿童会出现皮疹、发热和上呼吸道症状。该感染可导致多方面的临床表现,可能存在诊断不足的情况,尤其是在高危人群(患有溶血性贫血或免疫抑制的个体以及胎儿)中。现在,血清学诊断可以通过在各种体液或组织活检中使用PCR(聚合酶链反应)检测来证明病毒DNA进行补充。近年来,关于细小病毒B19相关并发症及其诊断和治疗的临床知识有了明显增加。